JPRN-C000000027已完成3 期
Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104) - Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 284 人开始时间: 2005年7月22日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 284
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Symptomatic brain metastasis 2) Double cancer 3) Superior vena cava syndrom 4) Massive pleural effusion or ascitis 5) Spiral compression 6) Severe hypertension 7) Diabetis melitus treated with insulin 8) Concommitant infectious disease excluded hepatic fever 9) Interstitial lung disease 10) Hypersinsitivity to Polysorbate 80 11) Need to treatment with steroid, ketoconazole, nifedipine or erithromycin 12) Psycologic illness 13) Women during pregbnancy or lacteted
研究者
相似试验
已完成
3 期
A Phase III Trial For Patients With Metastatic Breast CancerBreast NeoplasmsCancer of the BreastBreast CancerNCT00191152Eli Lilly and Company475
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)non-small-cell lung cancerJPRN-C000000146Japan Clinical Oncology Group(JCOG)230
已完成
3 期
Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)non-small-cell lung cancerJPRN-UMIN000001424Japan Clinical Oncology Group(JCOG)380
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Biological Targeted TreatmentSUCCESS B-Trial - SUCCESS-BPatientinnen mit primärem epithelialem invasivem MammakarzinomEUCTR2007-001094-29-DEKlinikum der LM
进行中（未招募）
不适用
Simultaneous Study of Gemcitabine-Docetaxel Combination adjuvant treatment, as well as Extended Bisphosphonate and Surveillance-Trial SUCCESS-Trial - SUCCESSThis is an open-label, multicenter, 2x2 factorial design, randomized controlled, Phase III study comparing the time to recurrence after randomisation in patients with early primary breast cancer.EUCTR2005-000490-21-DE1. Frauenklinik der LMU- Innenstadt